A Day Up For Wave Life Sciences Ltd.
Tue, Sep 24, 2024 at 07:43 PM
Wave Life Sciences Ltd. (WVE:NASDAQ) rocketted at $8.19, representing a gain of 53.4%. On Tue, Sep 24, 2024, WVE:NASDAQ touched a New 2-Week High of $8.19. The stock appeared on our News Catalysts scanner on Tue, Sep 24, 2024 at 05:36 PM in the 'PUBLIC OFFERING' category. From Tue, Sep 10, 2024, the stock recorded 30.00% Up Days and 36.36% Green Days
About Wave Life Sciences Ltd. (WVE:NASDAQ)
Wave Life Sciences Ltd is a preclinical therapeutics developer in Singapore. Its pipeline of drugs is intended to cure rare genetic disorders such as Huntington, duchenne muscular dystrophy (DMD) and inflammatory bowel disease.
Top 10 Gainers:
- BOQI International Medical Inc. (BIMI:NASDAQ), 650%
- Maison Solutions Inc. (MSS:NASDAQ), 115.86%
- Banzai International, Inc. Class A Common Stock (BNZI:NASDAQ), 96.19%
- XChange TEC.INC American Depositary Shares (XHG:NASDAQ), 93.55%
- Tempo Automation Holdings Inc. (TMPO:NASDAQ), 84.62%
- Seelos Therapeutics, Inc. (SEEL:NASDAQ), 57.37%
- Wave Life Sciences Ltd. (WVE:NASDAQ), 53.37%
- Capricor Therapeutics, Inc. (CAPR:NASDAQ), 52.43%
- DigiAsia Corp. (FAAS:NASDAQ), 47.86%
- Heart Test Laboratories, Inc. (HSCS:NASDAQ), 44.56%